Amit Hazan
Stock Analyst at Goldman Sachs
(2.09)
# 2,943
Out of 5,123 analysts
95
Total ratings
56.25%
Success rate
1.33%
Average return
Main Sectors:
Stocks Rated by Amit Hazan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Upgrades: Buy | n/a | $68.23 | - | 3 | Dec 13, 2022 | |
| BVS Bioventus | Maintains: Neutral | $13 → $2.5 | $8.10 | -69.14% | 5 | Nov 30, 2022 | |
| SKIN The Beauty Health Company | Maintains: Buy | $22 → $19 | $1.45 | +1,210.34% | 4 | Nov 23, 2022 | |
| SHC Sotera Health Company | Maintains: Neutral | $9 → $8 | $17.85 | -55.18% | 4 | Nov 23, 2022 | |
| LIVN LivaNova | Maintains: Buy | $73 → $63 | $65.43 | -3.71% | 3 | Nov 23, 2022 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $319 → $272 | $207.87 | +30.85% | 8 | Nov 23, 2022 | |
| BLCO Bausch + Lomb | Maintains: Neutral | $19 → $17 | $16.55 | +2.72% | 3 | Nov 23, 2022 | |
| OM Outset Medical | Maintains: Buy | $510 → $435 | $4.90 | +8,777.55% | 2 | Nov 9, 2022 | |
| PRCT PROCEPT BioRobotics | Maintains: Neutral | $39 → $44 | $28.93 | +52.09% | 2 | Nov 4, 2022 | |
| EW Edwards Lifesciences | Maintains: Neutral | $97 → $73 | $79.77 | -8.49% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $60 → $53 | $21.03 | +152.02% | 11 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $57 | $22.81 | +149.89% | 1 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $11 → $9.5 | $14.06 | -32.43% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $111 → $104 | $108.20 | -3.88% | 7 | Jul 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $60 | $19.06 | +214.80% | 3 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $129 → $115 | $101.84 | +12.92% | 9 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $248 → $150 | $360.66 | -58.41% | 2 | Apr 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $46 | $75.50 | -39.07% | 1 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $242 | $478.49 | -49.49% | 8 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $177 | $88.09 | +100.93% | 5 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $139 → $147 | $234.47 | -37.31% | 6 | Feb 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $3.5 → $3.9 | $0.76 | +415.46% | 3 | Nov 1, 2018 |
Inspire Medical Systems
Dec 13, 2022
Upgrades: Buy
Price Target: n/a
Current: $68.23
Upside: -
Bioventus
Nov 30, 2022
Maintains: Neutral
Price Target: $13 → $2.5
Current: $8.10
Upside: -69.14%
The Beauty Health Company
Nov 23, 2022
Maintains: Buy
Price Target: $22 → $19
Current: $1.45
Upside: +1,210.34%
Sotera Health Company
Nov 23, 2022
Maintains: Neutral
Price Target: $9 → $8
Current: $17.85
Upside: -55.18%
LivaNova
Nov 23, 2022
Maintains: Buy
Price Target: $73 → $63
Current: $65.43
Upside: -3.71%
Becton, Dickinson and Company
Nov 23, 2022
Maintains: Buy
Price Target: $319 → $272
Current: $207.87
Upside: +30.85%
Bausch + Lomb
Nov 23, 2022
Maintains: Neutral
Price Target: $19 → $17
Current: $16.55
Upside: +2.72%
Outset Medical
Nov 9, 2022
Maintains: Buy
Price Target: $510 → $435
Current: $4.90
Upside: +8,777.55%
PROCEPT BioRobotics
Nov 4, 2022
Maintains: Neutral
Price Target: $39 → $44
Current: $28.93
Upside: +52.09%
Edwards Lifesciences
Nov 3, 2022
Maintains: Neutral
Price Target: $97 → $73
Current: $79.77
Upside: -8.49%
Nov 3, 2022
Maintains: Sell
Price Target: $60 → $53
Current: $21.03
Upside: +152.02%
Oct 11, 2022
Initiates: Buy
Price Target: $57
Current: $22.81
Upside: +149.89%
Aug 8, 2022
Maintains: Neutral
Price Target: $11 → $9.5
Current: $14.06
Upside: -32.43%
Jul 25, 2022
Maintains: Sell
Price Target: $111 → $104
Current: $108.20
Upside: -3.88%
Jul 14, 2022
Maintains: Neutral
Price Target: $80 → $60
Current: $19.06
Upside: +214.80%
Jan 18, 2022
Maintains: Neutral
Price Target: $129 → $115
Current: $101.84
Upside: +12.92%
Apr 1, 2020
Downgrades: Sell
Price Target: $248 → $150
Current: $360.66
Upside: -58.41%
Feb 13, 2020
Initiates: Neutral
Price Target: $46
Current: $75.50
Upside: -39.07%
Feb 13, 2020
Initiates: Buy
Price Target: $242
Current: $478.49
Upside: -49.49%
Feb 13, 2020
Initiates: Buy
Price Target: $177
Current: $88.09
Upside: +100.93%
Feb 25, 2019
Maintains: Neutral
Price Target: $139 → $147
Current: $234.47
Upside: -37.31%
Nov 1, 2018
Upgrades: Neutral
Price Target: $3.5 → $3.9
Current: $0.76
Upside: +415.46%